A case of acute interstitial nephritis following the Pfizer-BioNTech COVID-19 vaccine
Nefrologia (Engl Ed)
.
2022 Sep-Oct;42(5):617-620.
doi: 10.1016/j.nefroe.2021.05.007.
Epub 2023 Jan 19.
Authors
José Carlos de la Flor Merino
1
,
Tania Linares Gravalos
2
,
Marina Alonso-Riaño
3
,
Pilar Segura Cebollada
4
,
Cristina Albarracin Serra
2
,
Elisa Ruiz Cicero
2
,
Gioconda Gallegos Bayas
2
,
Miguel Rodeles Del Pozoa
2
Affiliations
1
Servicio de Nefrología, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain. Electronic address: jflomer@mde.es.
2
Servicio de Nefrología, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
3
Servicio de Anatomía Patológica, Hospital 12 de octubre, Madrid, Spain.
4
Servicio de Medicina Preventiva, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
PMID:
36681520
PMCID:
PMC9851165
DOI:
10.1016/j.nefroe.2021.05.007
No abstract available
Publication types
Case Reports
Letter
MeSH terms
BNT162 Vaccine
COVID-19* / prevention & control
Humans
Nephritis, Interstitial* / chemically induced
Substances
BNT162 Vaccine
Supplementary concepts
Acute Tubulointerstitial Nephritis